RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 154 filers reported holding RA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 7.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $34,000 | -98.8% | 700 | -98.8% | 0.00% | -100.0% |
| Q4 2019 | $2,814,000 | +16452.9% | 59,962 | +8466.0% | 0.00% | – |
| Q3 2019 | $17,000 | -19.0% | 700 | -0.7% | 0.00% | – |
| Q2 2019 | $21,000 | +31.2% | 705 | +0.7% | 0.00% | – |
| Q1 2019 | $16,000 | +23.1% | 700 | -0.4% | 0.00% | – |
| Q4 2018 | $13,000 | -18.8% | 703 | -18.4% | 0.00% | – |
| Q3 2018 | $16,000 | – | 862 | +5287.5% | 0.00% | – |
| Q2 2018 | $0 | – | 16 | +128.6% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 7 | -99.3% | 0.00% | – |
| Q3 2017 | $16,000 | +220.0% | 1,069 | +381.5% | 0.00% | – |
| Q1 2017 | $5,000 | -37.5% | 222 | -55.2% | 0.00% | – |
| Q4 2016 | $8,000 | – | 495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,031,562 | $17,268,000 | 2.42% |
| NEA Management Company, LLC | 3,493,636 | $29,696,000 | 1.23% |
| VHCP Management II, LLC | 544,612 | $4,629,000 | 1.11% |
| RA Capital Management | 1,351,808 | $11,490,000 | 0.96% |
| Rock Springs Capital Management LP | 600,000 | $5,100,000 | 0.23% |
| Rhenman & Partners Asset Management AB | 108,451 | $922,000 | 0.12% |
| Tekla Capital Management LLC | 356,237 | $3,028,000 | 0.12% |
| ELLINGTON MANAGEMENT GROUP LLC | 34,900 | $297,000 | 0.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 79,150 | $673,000 | 0.03% |
| Candriam S.C.A. | 151,000 | $1,284,000 | 0.02% |